Modification of the existing maximum residue levels for fluazifop‐P in various products of plant and animal origin. (6th July 2017)

• Record Type: Journal Article
• Authors: Brancato, Alba; Brocca, Daniela; De Lentdecker, Chloé; Erdos, Zoltan; Ferreira, Lucien; Greco, Luna; Jarrah, Samira; Kardassi, Dimitra; Leuschner, Renata; Lythgo, Christopher; Medina, Paula; Miron, Ileana; Molnar, Tunde; Nougadere, Alexandre; Pedersen, Ragnor; Reich, Hermine; Sacchi, Angela; Santos, Miguel; Stanek, Alois; Sturma, Juergen; Tarazona, José; Theobald, Anne; Vagenende, Benedicte; Verani, Alessia; Villamar‐Bouza, Laura
• Is Part Of: EFSA journal. Volume 15:Number 7(2017)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2017-07-06
• Subjects: fluazifop‐P -- carrot -- tomato -- courgette -- pesticide -- MRL -- consumer risk assessment; Food -- Europe -- Safety measures -- Periodicals; Food Safety; Food -- Safety measures; Europe; Periodicals; Periodicals; Fulltext; Government Publications, International; Internet Resources; Periodicals; Periodicals; 363.19209405
• DOI: 10.2903/j.efsa.2017.4871
• Languages: English
• ISSNs: 1831-4732

Abstract

Abstract: In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Syngenta Crop Protection AG submitted a request to the competent national authority in Portugal to modify the existing maximum residue levels (MRL) for the active substance fluazifop‐P in tomato, carrot and courgette. The data submitted in support of the request were found to be sufficient to derive MRL proposals for carrot and courgette. For tomato, data gaps were identified which precluded the derivation of MRL proposal. Adequate analytical methods for enforcement are available to control the residues of fluazifop‐P in plant matrices under consideration. Based on the risk assessment results, EFSA concluded that the short‐term and long‐term intake of residues resulting from the use of fluazifop‐P on carrots and courgettes according to the reported agricultural practices and the products of animal origin under consideration is unlikely to present a risk to consumer health.